GENEVA, June 19 -- CDMOGEN CO., LTD filed a patent application (KR2025/018484) for “AAV-BASED PDE6B VIRAL VECTOR FOR TREATING RETINITIS PIGMENTOSA CONTAINING TISSUE-SPECIFICALLY EXPRESSED PDE6A PROMOTER, AND USE THEREOF”. With publication no. WO/2026/106270, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 48/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....